Assessing the costs and benefits of perioperative iron deficiency anemia management with ferric carboxymaltose in Germany

BACKGROUND: Perioperative administration of ferric carboxymaltose (FCM) was previously shown to reduce both the need for transfusions and the hospital length of stay in patients with preoperative iron deficiency anemia (IDA). In this study, we estimated the economic consequences of perioperative adm...

Descripción completa

Detalles Bibliográficos
Autores principales: Froessler, Bernd, Rueger, Alexandra M, Connolly, Mark P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923254/
https://www.ncbi.nlm.nih.gov/pubmed/29731670
http://dx.doi.org/10.2147/RMHP.S157379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923254/
https://www.ncbi.nlm.nih.gov/pubmed/29731670
http://dx.doi.org/10.2147/RMHP.S157379

Ejemplares similares